Recordati Bid Pulls Italian Pharma Deeper Into Private Equity Hands
Recordati bid moves Italian pharma deeper into private equity hands as CVC and GBL launch a €10.7 billion offer, raising questions about consolidation, capital structure, and future dealmaking in Europe.
Samuel Berrit OlamMay 24, 2026
